Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatography Pancreatitis. (PEPLID)
ERCP Surgery
About this trial
This is an interventional treatment trial for ERCP Surgery
Eligibility Criteria
Inclusion Criteria: Patient over 18 years of age Patient who has read and signed the consent form for participation in the study Patient candidate for ERCP with virgin papilla Exclusion Criteria: Patient with sphincterotomized papilla Patient under court protection, guardianship or curatorship Pregnant woman or woman of childbearing age without highly effective contraception for the duration of the study (surgically sterile, intrauterine device (> 14 days), hormonal contraception (same dose and formulation for at least 6 months), sexual abstinence. Women after menarche and until they become postmenopausal, unless they are permanently infertile or have undergone surgical sterilization, are considered to be of childbearing age, i.e. fertile. A postmenopausal condition is defined as the absence of menstruation for 12 months without any other medical cause Patient not affiliated with the French social security system Patient participating in another clinical research protocol Impossibility to give the subject informed information and/or written informed consent: dementia, psychosis, disorders of consciousness, non-French speaking patient Contraindication to the use of NSAIDs Contraindication to anesthesia or to the administration of any of the products used in anesthesia protocols (including lidocaine)
Sites / Locations
- Hôpital Privé des Peupliers
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
General anesthesia without intravenous lidocaine administration
General anesthesia with intravenous lidocaine administration